• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT SYSTEM Back to Search Results
Catalog Number 1011710-38
Device Problems Detachment Of Device Component (1104); Deflation Problem (1149); Difficult to Remove (1528)
Patient Problems Angina (1710); Death (1802); Fever (1858)
Event Date 02/05/2018
Event Type  Death  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The stent remains in the patient.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the patient had been experiencing chest pain for one year.The procedure was to treat a mid left anterior descending artery that was 90% stenosed.A 3.5 x 38 mm xience prime stent delivery system (sds) was advanced and inflated to 12 atmospheres; however, there was resistance during attempted withdrawal because the balloon did not deflate.An attempt was made to deflate the balloon by puncturing it with a guide wire but it failed.The balloon finally broke into two pieces in the anatomy.The patient experienced chest pain and fever and was transferred to another hospital for emergency coronary artery bypass surgery (cabg).The stent delivery system was removed post-operatively through thoracotomy.The patient expired after surgery the same day.The cause of death is unknown.No additional information was provided.
 
Manufacturer Narrative
(b)(4).The device was returned for analysis.The reported detachment of a device component was confirmed.The reported deflation issues and difficulty to remove could not be confirmed as the device condition prevented any functional testing from being performed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.A cine was received and reviewed by an abbott vascular clinical specialist.The reviewer concluded it is noted within the images provided that the stent system balloon used to treat the proximal lad did not fully deflate.It appears that the distal end of the stent system is irregularly shaped.The initial inflation was done at 15:50.The last image received was timed at 16:25.This means that the balloon was partially inflated in the proximal lad for a minimum of 35 minutes.It is seen that attempts were made to re-inflate and deflate the balloon.The reported patient effects of angina, fever and death are listed in the xience prime, everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.The investigation was unable to determine a conclusive cause for the reported deflation issues; however, the difficulty to remove and detachment of a device component with the patient effects of angina appear to be related to operational context of the procedure.Additionally, the investigation was unable to determine a conclusive cause for the reported patient effects of fever and death, and the relationship to the device, if any.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
CLONMEL, IRELAND REG# 9616693
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key7307603
MDR Text Key101311526
Report Number2024168-2018-01488
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 04/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/20/2020
Device Catalogue Number1011710-38
Device Lot Number7061241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/26/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/01/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
-
-